| 2024 | Development of an Ephedrine In-House Matrix Reference Material and Its Application to Doping Analysis | 이화정 | Article |
| 2024 | Cardioprotective Effects of PARP Inhibitors: A Re-Analysis of a Meta-Analysis and a Real-Word Data Analysis Using the FAERS Database | 김명규 | Article |
| 2024 | A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin | 김우성 | Article |
| 2024 | Standigm ASK™: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis | 이윤실 | Article |
| 2022 | Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
| 2023 | Construction of a risk scoring system using clinical factors and <i>RYR2</i> polymorphisms for bleeding complications in patients on direct oral anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
| 2023 | ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban | 곽혜선; 박준범; 송태진; 이정; 김동혁 | Article |
| 2023 | Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
| 2023 | Association between <i>SLCO1B1</i> genetic polymorphisms and bleeding risk in patients treated with edoxaban | 곽혜선; 박준범; 송태진; 이정; 김동혁 | Article |
| 2022 | Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
